Diabetes & CV Disease
Sort by:
John Tayek
2020 Updates on Insulin Therapy: What Are the Current ADA Standards of Care?
- 2,466 views
- November 25, 2020
- 13
Primary Care Education Consortium
A Pathophysiologic Approach for Treating Type 2 Diabetes: Part 2
FEATURING
Eden Miller
- 2,353 views
- November 30, 2023
- 20
Practical Ways to Achieve Targets in Diabetes Care
ADA/EASD Guidelines 2023
FEATURING
Anne Peters
- 2,328 views
- August 23, 2023
- 13
Practical Ways to Achieve Targets in Diabetes Care
ATDC 2022 Pioglitazone: Summary of Current Knowledge
FEATURING
Steven Nissen
- 2,324 views
- August 23, 2022
- 22
Emory Diabetes Education Training Academy
Insulin Treatment in Patients with Type 2 Diabetes: When and How to Start Insulin Therapy
FEATURING
Guillermo Umpierrez
- 2,295 views
- May 15, 2020
- 12
Texas Cardiovascular Innovations Conference 2021
New Heart Failure Treatment Recommendations
FEATURING
Albert Hicks
- 2,272 views
- March 3, 2022
- 14
Practical Ways to Achieve Targets in Diabetes Care
ATDC 2022: The Ominous Octet and More
FEATURING
Ralph DeFronzo
- 2,269 views
- July 27, 2022
- 20
The Texas Heart Institute
Use of Finerenone in Patients with Diabetes Who Have Kidney Disease
FEATURING
George Bakris
- 2,248 views
- September 7, 2023
- 25
Stanford Medicine
Animal vs. Vegetable: Does Food Type Matter?
FEATURING
Christopher Gardner
- 2,247 views
- September 13, 2023
- 20
Symposium on Diabetes and Cancer 2017: Novel Links and Treatments
Obesity, Diabetes and Cancer Risk
FEATURING
Derek LeRoith
- 2,237 views
- June 16, 2017
- 8
Cleveland Clinic Endocrinology & Metabolism Institute
Diabetes Management in CKD: KDIGO 2022 Clinical Practice Update
FEATURING
Luiza Caramori
- 2,212 views
- June 20, 2023
- 18
Cleveland Clinic | 12th Annual Obesity Summit
Management of Hypertension and Hyperlipidemia in Type 2 Diabetes
FEATURING
Steven Nissen
- 2,151 views
- December 3, 2017
- 8
Susan Brian
Discussing Retatrutide: A GIP, GLP-1, and Glucagon Receptor Agonist
- 2,149 views
- January 26, 2024
- 40
Symposium on Diabetes and Cancer 2017: Novel Links and Treatments
The Effect of Cancer Therapies on Diabetes
FEATURING
Emily J Gallagher
- 2,115 views
- June 16, 2017
- 13
Cleveland Clinic | 12th Annual Obesity Summit
What To Do After Metformin: GLP-1, SGLT2 or DPP-4?
FEATURING
Kevin Pantalone
- 2,114 views
- December 3, 2017
- 5
Primary Care Education Consortium
A Pathophysiologic Approach for Treating Type 2 Diabetes: Part 1
FEATURING
Louis Kuritzky
- 2,110 views
- November 30, 2023
- 13
Susan Brian
The Differences Between the Products of GLP1's and GLP/GIPs
- 2,104 views
- January 29, 2024
- 36
Emory Diabetes Education Training Academy
Update in Diabetes and Cardiovascular Health
FEATURING
Guillermo Umpierrez
- 2,099 views
- February 17, 2022
- 11
AHA 2023 Insights
AHA 2023 Insights: Reflections on SELECT Trial
FEATURING
Donna Ryan
- 2,070 views
- November 21, 2023
- 11
Silva Arslanian
Once-Weekly Subcutaneous Semaglutide 2.4 mg in Adolescents with Obesity
- 2,050 views
- February 9, 2023
- 13
San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians
Recognizing and Treating HFpEF: How Helpful Are MRAs, ARNi and SGLT2 Inhibitors for Treating Patients? What Have We Learned From The PARADIGM and PARAGON Trials?
FEATURING
Barry Greenberg
- 2,010 views
- February 5, 2021
- 22